Psoriasis and the new biologic agents: interrupting a T-AP dance

Walsh, Scott R. A.; Shear, Neil H.
June 2004
CMAJ: Canadian Medical Association Journal;6/22/2004, Vol. 170 Issue 13, p1933
Academic Journal
PSORIASIS IS AN IMMUNE-MEDIATED SKIN DISEASE in which chronic T-cell stimulation by antigen-presenting cells (APC) occurs in the skin. This interplay between the T-cell and APC has been likened to a "T-AP dance" where specific steps must occur in sequence to result in T-cell activation and the disease phenotype; otherwise T-cell anergy would occur. Several novel engineered proteins designed to block specific steps in immune activation (biologic agents) have demonstrated efficacy in the treatment of psoriasis. These agents include fusion proteins, monoclonal antibodies and recombinant cytokines. These medications act at specific steps during the T-AP dance either to inhibit T-cell activation, costimulation and subsequent proliferation of T-cells, lead to immune deviation or induce specific cytokine blockades. The potential increased selectivity for specific pathways in immune activation, clinical efficacy and relative safety of these new agents offers an alternative for the treatment of moderate to severe psoriasis.


Related Articles

  • Vitamin D Controls Murine and Human Plasmacytoid Dendritic Cell Function. Karthaus, Nina; van Spriel, Annemiek B; Looman, Maaike W G; Chen, Shuo; Spilgies, Lisanne M; Lieben, Liesbet; Carmeliet, Geert; Ansems, Marleen; Adema, Gosse J // Journal of Investigative Dermatology;May2014, Vol. 134 Issue 5, p1255 

    Topical application of the vitamin D (VitD) analog calcipotriol is a highly effective standard treatment modality of psoriatic skin lesions. However, the immune modulatory effects of the treatment are incompletely understood. VitD is well known to induce tolerogenic responses in conventional...

  • Direct and Indirect Control of T-Cell Activation by Keratinocytes. Nickoloff, Brian J.; Turka, Laurence A.; Mitra, Raj S.; Nestle, Frank O. // Journal of Investigative Dermatology;Jul95 Supplement, Vol. 105, p25S 

    Keratinocytes can function as antigen-presenting cells/accessory cells and regulate T cells with three distinct outcomes, depending on the nature of the stimulus. In the presence of alloantigen, it appears that a "null" event takes place between T cells and keratinocytes, with neither activation...

  • In Brief.  // Nature Reviews Immunology;Jan2011, Vol. 11 Issue 1, p4 

    The article offers news brief related to immunology research. Immunology researchers has revealed the synergy between the plexin A4 signalling and toll-like receptor (TLR) in promoting pro-inflammatory cytokine responses. A medical research has revealed prognosis of chronic skin inflammation of...

  • Mechanisms of Cyclosporine A Inhibition of Antigen-Presenting Activity in Uninvolved and Lesional Psoriatic Epidermis. Cooper, Kevin D.; Baadsgaard, Ole; Ellis, Charles N.; Duell, Elizabeth; Voorhees, John J. // Journal of Investigative Dermatology;May90, Vol. 94 Issue 5, p649 

    To elucidate how cyclosporine A affects antigen-presenting cell subsets and their function in human skin, we studied patients with psoriasis undergoing a therapeutic trial of cyclosporine A. Immunologic parameters abnormal in psoriatic epidermis were evaluated before and early in the course of...

  • Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis. Res, Pieter C. M.; Piskin, Gamze; de Boer, Onno J.; van der Loos, Chris M.; Teeling, Peter; Bos, Jan D.; Teunissen, Marcel B. M. // PLoS ONE;2010, Vol. 5 Issue 11, p1 

    Background: Although recent studies indicate a crucial role for IL-17A and IL-22 producing T cells in the pathogenesis of psoriasis, limited information is available on their frequency and heterogeneity and their distribution in skin in situ. Methodology/Principal Findings: By spectral imaging...

  • CURRENT CONCEPTS IN THE PATHOGENESIS OF PSORIASIS. Das, Rajeev Patrick; Jain, Arun Kumar; Ramesh, V. // Indian Journal of Dermatology;Jan-Mar2009, Vol. 54 Issue 1, p7 

    Psoriasis is a multi-factorial skin disease with a complex pathogenesis. Various factors which have been suggested to play a key role in the pathogenesis are T cells, antigen presenting cells (APC's), keratinocytes, Langerhans' cells, macrophages, natural killer cells, an array of Th1 type...

  • Immunobiologic Agents in Dermatology. Şendur, Neslihan // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Aug2007, Vol. 6 Issue 3, p180 

    In recent years, the role of T cells, dentritic antigen presenting cells (APCs) and cytokine network in inflammatory dermatoses has been more completely understood. This in turn has enabled the completion of new potentials and goals in immunotherapy. As research in Immunodermatology increased,...

  • Cutaneous immunology: basics and new concepts. Yazdi, Amir; Röcken, Martin; Ghoreschi, Kamran // Seminars in Immunopathology;Jan2016, Vol. 38 Issue 1, p3 

    As one of the largest organs, the skin forms a mechanical and immunological barrier to the environment. The skin immune system harbors cells of the innate immune system and cells of the adaptive immune system. Signals of the innate immune system typically initiate skin immune responses, while...

  • Macrophage Inflammatory Protein-1α (MIP-1α). Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p421 

    A definition of the term "Macrophage Inflammatory Protein-1α" is presented. It refers to a CC chemokine also known as CCL3. Binds to CCR5, an HIV co-receptor.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics